Dendritic cells from nonobese diabetic mice exhibit a defect in NF-κB regulation due to a hyperactive IκB kinase

Journal of Immunology

Volumn 167, Issue 3, 2001, Pages 1461-1468

  Weaver D J , Jr ^a   Poligone, B ^a   Bui, T ^a   Abdel Motal, U M ^a   Baldwin A S , Jr ^a   Tisch, R ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; CELL DESTRUCTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; INSULIN DEPENDENT DIABETES MELLITUS; MACROPHAGE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; TH1 CELL;

EID: 0035424898     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.3.1461     Document Type: Article

References (53)

1. null mice are diabetes and insulitis resistant
2. Insulin-dependent diabetes mellitus
3. + T cells
4. Cytokines induce the development of functionally heterogeneous T helper cell subsets
5. + T cell responses: The alternative approaches
6. Aberrant macrophage cytokine production is a conserved feature among autoimmune-prone mouse strains: Elevated interleukin (IL)-12 and an imbalance in tumor necrosis factor-α and IL-10 define a unique cytokine profile in macrophages from young nonobese diabetic mice
7. The role of macrophages in T cell-mediated autoimmune diabetes in nonobese diabetic mice
8. Splenic macrophages from the NOD mouse are defective in the ability to present antigen
9. Dendritic cells induce autoimmune diabetes and maintain disease via de novo formation of local lymphoid tissue
10. Defects in the differentiation and function of antigen presenting cells in NOD/Lt mice
11. Hematopoietic stem-cell defects underlying abnormal macrophage development and maturation in NOD/Lt mice: Defective regulation of cytokine receptors and protein kinase C
12. Dendritic cells and the control of immunity
13. Mobilizing dendritic cells for tolerance, priming, and chronic inflammation
14. Interaction of dendritic cells with skin endothelium: A new perspective on immunosurveillance
15. Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking
16. Autocrine IL-12 is involved in dendritic cell modulation via CD40 ligation
17. NF-κB and Rel proteins: Evolutionarily conserved mediators of immune responses
18. IL-12 induces SDS-stable class II αβ dimers in murine dendritic cells
19. Vascular endothelial growth factor affects dendritic cell maturation through the inhibition of nuclear factor-κB activation in hemopoietic progenitor cells
20. Dendritic cell survival and maturation are regulated by different signaling pathways
21. + dendritic cells
22. N-acetyl-L-cysteine inhibits primary human T cell responses at the dendritic cell level: Association with NF-κB inhibition
23. NF-κB activation provides the potential link between inflammation and hyperplasia in the arthritic joint
24. The NF-κB and IκB proteins: New discoveries and insights
25. Identification and characterization of an IκB kinase
26. IκB-β regulates the persistent response in a biphasic activation of NF-κB
27. Distinct functional properties of IκBα and IκBβ
28. IκB epsilon, a novel member of the IκB family, controls RelA and cRel NF-κB activity
29. Mechanisms by which IκB proteins control NF-κB activity
30. Cloning and functional characterization of mouse 1κBε
31. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/Rel family
32. Regulation of interleukin 12 p40 expression through an NF-κB half-site
33. cis-acting sequences required for class II gene regulation by interferon γ and tumor necrosis factor α in a murine macrophage cell line
34. Synergistic activation of NF-κB by tumor necrosis factor α and γ interferon via enhanced IκBα degradation and de novo IκBβ degradation
35. Involvement of Egr-1/RelA synergy in distinguishing T cell activation from tumor necrosis factor-α-induced NF-κB1 transcription
36. T cell genetic background determines default T helper phenotype development in vitro
37. Tumor necrosis factor-α and the progression of diabetes in non-obese diabetic mice
38. Dendritic cells and macrophages are the first and major producers of TNF-α in pancreatic islets in the nonobese diabetic mouse
39. Genetic mapping of a murine locus controlling development of T helper 1/T helper 2 type responses
40. Genetic susceptibility to Leishmania: IL-12 responsiveness in TH1 cell development
41. NOD mice are defective in proteasome production and activation of NF-κB
42. Essential role of human leukocyte antigen-encoded proteasome subunits in NF-κB activation and prevention of tumor necrosis factor-α-induced apoptosis
43. LMP2 expression and proteasome activity in NOD mice
44. LMP2 expression and proteasome activity in NOD mice
45. The IκB kinase complex (IKK) contains two kinase subunits, IKKα and IKKβ, necessary for IκB phosphorylation and NF-κB activation
46. Lineage-restricted function of nuclear factor κB-inducing kinase (NIK) in transducing signals via CD40
47. RelB modulation of IκBα stability as a mechanism of transcription suppression of interleukin-1α (IL-1α), IL-1β, and tumor necrosis factor alpha in fibroblasts
48. A20 zinc finger protein inhibits TNF and IL-1 signaling
49. Recruitment of the IKK signalosome to the p55 TNF receptor: RIP and A20 bind to NEMO (IKK) upon receptor stimulation
50. A defect in interleukin 12-induced activation and interferon gamma secretion of peripheral natural killer T cells in nonobese diabetic mice suggests new pathogenic mechanisms for insulin-dependent diabetes mellitus
51. Immunotherapy of NOD mice with bone marrow-derived dendritic cells
52. Prevention of spontaneous autoimmune diabetes in NOD mice by transferring in vitro antigen-pulsed syngeneic dendritic cells
53. Immunobiology of dendritic cells